Coronavirus drug update: Cipla, Hetero to launch Remdesivir at Rs 3,000-6,000 - BusinessToday
Gilead Tests An Inhalable Form of Intravenous Remdesivir | Time
Frühe Therapie bei COVID-19 sinnvoll: Remdesivir zur Inhalation?
Discovery of SARS-CoV-2 antiviral synergy between remdesivir and approved drugs in human lung cells | Scientific Reports
In vivo pharmacokinetic study of remdesivir dry powder for inhalation in hamsters - ScienceDirect
Gilead to Begin Human Testing of Inhaled Version of Covid-19 Drug Remdesivir - WSJ
Remdesivir: How does the government decide who gets this coronavirus treatment? Doctors have no idea | CNN
COVID-19 Remedy?: High Hopes for Remdesivir in the Coronavirus Fight - DER SPIEGEL
Frühe Therapie bei COVID-19 sinnvoll: Remdesivir zur Inhalation?
Inhaled formulation of remdesivir enters clinical trials
Liposomal remdesivir inhalation solution for targeted lung delivery as a novel therapeutic approach for COVID-19 - ScienceDirect
Remdesivir Tests for Covid Treatments Enter New Phase - The New York Times
Frühe Therapie bei COVID-19 sinnvoll: Remdesivir zur Inhalation?
Gilead to study inhaled remdesivir on COVID-19 patients
Dry Powder Inhalation Could Be a Potent Tool in COVID-19 Antiviral Treatment - UT News
COVID-19 therapeutics: Challenges and directions for the future | PNAS
Study Confirms Remdesivir's Benefits for Coronavirus | Time
Remdesivir-Metabolit noch schärfere Waffe gegen Covid-19
COVID-19: Hersteller testet inhalative Version von Remdesivir
Researchers develop dry powder remdesivir to strike COVID-19 where it counts | Fierce Pharma
New studies clarify what drugs help, hurt for COVID-19
Gilead announces long-awaited price for Covid-19 drug remdesivir - STAT
Pharmaceutics | Free Full-Text | Development of Remdesivir as a Dry Powder for Inhalation by Thin Film Freezing
Remdesivir ist zugelassen | APOTHEKE ADHOC
Inhalatives Remdesivir wird getestet | PZ – Pharmazeutische Zeitung
